News
Purnovate LLC is acquired by Adial Pharma and with it AD 04 a proposed treatment for alcohol dependence
Adial Pharmaceuticals, Inc. announced that it has entered into a definitive agreement to acquire Purnovate, LLC a pharmaceutical development company focused on novel, drug candidates for non-opioid pain reduction and the treatment of addiction and other diseases through targeted use of adenosine analogs with promising potency, selectivity, stability, and solubility characteristics.
Type: industry
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
